Detalhe da pesquisa
1.
Potential Benefit of Add-on Δ9-Tetrahydrocannabinol in Pediatric Drug-Resistant Epilepsy: A Case Series.
Can J Neurol Sci
; 49(4): 595-597, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34183079
2.
Does treatment have an impact on incidence and risk factors for autism spectrum disorders in children with infantile spasms?
Epilepsia
; 56(6): 856-63, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25944453
3.
A randomized controlled trial of flunarizine as add-on therapy and effect on cognitive outcome in children with infantile spasms.
Epilepsia
; 53(9): 1570-6, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22889307
4.
What is the optimal duration for vigabatrin monotherapy in patients with infantile spasms: 6 months or longer?
Seizure
; 91: 503-506, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34371246
5.
Cognitive outcome in children with infantile spasms using a standardized treatment protocol. A five-year longitudinal study.
Seizure
; 89: 73-80, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34020345
6.
Predictive Factors for Epilepsy in Pediatric Patients With Sturge-Weber Syndrome.
Pediatr Neurol
; 64: 52-58, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27637568